ClinicalTrials.Veeva

Menu

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

H

Hisamitsu Pharmaceutical

Status and phase

Completed
Phase 3

Conditions

Osteoarthritis of the Knee

Treatments

Drug: ketoprofen Patch
Other: Placebo Patch

Study type

Interventional

Funder types

Industry

Identifiers

NCT00792727
HKT-500-US07

Details and patient eligibility

About

Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.

Full description

The objective of this study is to demonstrate the short-term multiple dose efficacy and safety of HKT-500 in subjects with pain caused by mild to moderate osteoarthritis of the knee. The goal of the study is to gather additional information about the analgesic efficacy and safety of repeated, 24-hour applications of 2 HKT-500 patches per knee for a total of 28 days in subjects with pain caused by mild to moderate osteoarthritis of the knee.

Enrollment

380 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • man or woman ≥45 years of age.
  • clinical diagnosis of unilateral or bilateral OA of the knee
  • taking an NSAID or acetaminophen on a regular basis and has a history of knee pain amelioration with NSAID or acetaminophen use.
  • mild to moderate OA of the knee at the screening visit
  • subject exhibits an arthritis "flare" in the target knee within 7 days day of withdrawing from a NSAID or acetaminophen.
  • subject understands that treatment will be administered on an inpatient basis.
  • subject is capable of understanding and complying with the protocol and has signed the informed consent document.

Exclusion criteria

  • subject is a woman of childbearing potential who has a positive urine pregnancy test, is lactating, or who is not surgically sterile
  • subject has symptoms that are attributable to primary inflammatory diseases of the joint
  • subject has unstable knees including a history of the knee catching or giving way or physical examination evidence of instability
  • subject has arthropathies that occur in conjunction with systemic diseases
  • subject has a chronic pain condition
  • subject is grossly obese
  • subject has a history of knee surgery within the past 12 months or arthroscopy within the past 6 months.
  • subject has a history of osteotomies.
  • subject is not willing to discontinue the use of NSAIDs, acetaminophen or other prohibited treatments
  • subject used opioids for OA pain within 1 month

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

380 participants in 2 patient groups, including a placebo group

Ketoprofen Patch
Experimental group
Description:
Treatment with experimental drug
Treatment:
Drug: ketoprofen Patch
Placebo Patch
Placebo Comparator group
Description:
Treatment with placebo drug
Treatment:
Other: Placebo Patch

Trial contacts and locations

36

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems